During the past decade, Mid America Heart Institute conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 23 clinical trials were completed, i.e. on average, 79.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mid America Heart Institute" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 12 trials, followed by "Edwards Lifesciences" with 9 trials sponsored, "Saint Luke's Health System" with 4 trials sponsored, "Yale University" with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mid America Heart Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Acelis Connected Health" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Mid America Heart Institute" are "Heart Failure" (8 trials), "Coronary Artery Disease" (7 trials), "Heart Diseases" (5 trials), "Aortic Stenosis" (4 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "Mid America Heart Institute" in a lesser frequency.

Most popular intervention types in "Mid America Heart Institute" are "Device" (39 trials), "Drug" (12 trials), "Other" (5 trials), "Procedure" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Micra Pacemaker Implant" (2 trials), "Standard of Care" (2 trials), "TAVR Implantation with SAPIEN XT" (2 trials) and "Ad5FGF-4" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mid America Heart Institute" are 66 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mid America Heart Institute". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Mid America Heart Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Mid America Heart Institute, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 28 trials that are defined as “Not Applicable".